Your spin on what I reported is not even remotely plausible. Back to the drawing board for you.
Haha. I love when I get responses like this. Bet you don't respond to this question:
What did I say that you didn't already say, or what do you disagree with?
Let's take a look at my points.
1) No NYSA response. Your counter to this will be "they are working on getting the articles revised" but that is not a response. They will have no public response to the attacks. Which means the attacks worked - doesn't matter if the articles get deleted now, that toothpaste is out of the tube. Also, the investors are probably doing most of the heavy lifting on that front. 2) Can't say anything til journal release. Is that false? 3) No timeline on when journal release will be. Is that false? 4) ASCO is a dud. You literally said this yourself ("ASCO may not be the big moment we are waiting for")
So what here aren't you seeing eye to eye with me on? What isn't remotely plausible? Would love to know where my interpretation went askew.
Always appreciate for your feedback from conversation you had with DI. Don't worry about other people's comment. If they do not like the feedback, they should contact DI to voice their concern directly. I remember I have read it somewhere that the final peer reviewed version of publication has been submitted to Journal during March, 2022. Do you know is that true? If true, it should not take long for journal to publish it.
Market Data 
Markets 
AI
